Hedge fund titan David Tepper has made some key portfolio moves in Q2, as revealed by 13F forms filed with the SEC …
Valeant’s a Deep Shade of Grey All eyes are on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as the Street wonders if this troubled biotech …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) released a grim second quarter print last Thursday, revealing that the management team had lowered guidance across …
Is Teva Pharmaceutical a Falling Knife to Catch After Plunging over 30%? This week turned out to be a nightmare for shareholders of Teva …
Teva Falling Under Sends Oppenheimer to the Sidelines Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is looking at having to slash 7,000 jobs from …
Investors continue to dump shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after the pharmaceutical giant reported lower-than-expected second-quarter earnings. Specifically, Teva reported revenues …
Valeant’s Siliq Not Competitive Enough in Psoriasis Market Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) fighting chances in the drug arena to compete may have just …
Top analyst Irina Rivkind Koffler at Mizuho is out today sounding the alarm on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) in a research report today, …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares are falling nearly 7% following CEO Erez Vigodman’s exit, leaving current chairman Dr. Yitzhak Peterburg to …
Top analyst Irina Rivkind Koffler at Mizuho is taking a sharp left from the sidelines on Eagle Pharmaceuticals Inc (NASDAQ:EGRX) on the heels …
